Colchicine for first-time blood clot in the leg
Treatments studied
Part of Heart & circulation clinical trials.
This study tests whether adding the drug colchicine to standard blood-thinner treatment can help people with a first blood clot in their leg. Colchicine is an anti-inflammatory medicine that may reduce the risk of another clot and related complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must have a first blood clot in your thigh or behind the knee, diagnosed in the last 48 hours.
- You will be starting standard blood-thinner medication.
- You cannot have had a blood clot in the same leg before.
- You cannot be taking or need to take colchicine, and you must not be allergic to it.
- You cannot have severe liver or kidney disease, active cancer with short life expectancy, or chronic digestive problems.
- You cannot have recently used immune-suppressing drugs or have had major bleeding in the last 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a clot-removal device (ClotTriever) plus standard care versus standard blood thinners alone for a deep vein clot in the leg. It aims to see which approach better improves leg symptoms and outcomes.
This trial tests whether taking a statin (rosuvastatin) after a recent leg blood clot (DVT) and/or lung blood clot (PE) can lower the chance of future venous clots. You might benefit if you’re at risk for more clotting and can take the study medication safely.
This trial tests if colchicine, a medicine used for gout, can reduce inflammation after a first deep vein thrombosis (blood clot in a large leg vein). It might help prevent long-term leg problems from the clot.
This study tests whether a medication called colchicine can help prevent amputation in people with severe leg blood flow problems who just had surgery or a catheter procedure to restore blood flow. Colchicine is an anti-inflammatory drug that may help protect the leg tissue after treatment.
This study tests whether taking a daily low dose of colchicine, a medicine used for inflammation, can help prevent a first heart attack or other heart problems in people who are at higher risk due to their risk factors. If you qualify, you would be assigned to take either colchicine or a placebo (a pill with no active medicine) to see if it helps keep your heart healthy.
This trial tests whether low-dose colchicine can reduce “residual” risk—future heart and blood-vessel problems—in people with peripheral artery disease (PAD). It targets PAD symptoms and complications like poor blood flow in the legs, even after certain procedures.
Hear when a new Post Thrombotic Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.